Bedaquiline
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB08903 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | tuberculosis, bovine | KG + DL |
| 2 | tuberculosis, avian | KG + DL |
| 3 | tuberculous ascites | KG + DL |
| 4 | tuberculoma | KG + DL |
| 5 | inactive tuberculosis | KG + DL |
| 6 | vulvovaginal candidiasis | KG + DL |
| 7 | fascioliasis | KG + DL |
| 8 | urea cycle disorder | KG + DL |
| 9 | cutaneous tuberculosis | KG + DL |
| 10 | esophageal candidiasis | KG + DL |
| 11 | inhalational botulism | KG + DL |
| 12 | helminthiasis, animal | KG + DL |
| 13 | metagonimiasis | KG + DL |
| 14 | monieziasis | KG + DL |
| 15 | fasciolopsiasis | KG + DL |
| 16 | fascioloidiasis | KG + DL |
| 17 | necatoriasis | KG + DL |
| 18 | paragonimiasis | KG + DL |
| 19 | echinostomiasis | KG + DL |
| 20 | acanthocephaliasis | KG + DL |
| 21 | dicrocoeliasis | KG + DL |
| 22 | hymenolepiasis | KG + DL |
| 23 | clonorchiasis | KG + DL |
| 24 | gnathomiasis | KG + DL |
| 25 | staphylococcal scalded skin syndrome | KG + DL |
| 26 | toxin-mediated infectious botulism | KG + DL |
| 27 | allergic urticaria | KG + DL |
| 28 | angiostrongyliasis | KG + DL |
| 29 | Clostridium infectious disease | KG + DL |
| 30 | opisthorchiasis | KG + DL |
| 31 | bullous impetigo | KG + DL |
| 32 | extrapulmonary tuberculosis | KG + DL |
| 33 | intestinal helminthiasis | KG + DL |
| 34 | hordeolum | KG + DL |
| 35 | acute neonatal citrullinemia type I | KG + DL |
| 36 | adult-onset citrullinemia type I | KG + DL |
| 37 | neonatal candidiasis | KG + DL |
| 38 | candida glabrata | KG + DL |
| 39 | congenital candidiasis | KG + DL |
| 40 | candidiasis, invasive | KG + DL |
| 41 | staphylococcus aureus pneumonia | KG + DL |
| 42 | punctate epithelial keratoconjunctivitis | KG + DL |
| 43 | mycetoma | KG + DL |
| 44 | Legionnaires’ disease | KG + DL |
| 45 | giardiasis | KG + DL |
| 46 | impetigo | KG + DL |
| 47 | cardiac tuberculosis | KG + DL |
| 48 | papillary conjunctivitis | KG + DL |
| 49 | leishmaniasis, diffuse cutaneous | KG + DL |
| 50 | disseminated candidiasis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.